Loading...
|
Please use this identifier to cite or link to this item:
https://nccur.lib.nccu.edu.tw/handle/140.119/112846
|
| Title: | 研究台灣人類乳突病毒疫苗施打政策: 評估實施策略
A Study of Human Papillomavirus Vaccination Policy in Taiwan: Focusing on the Evaluation of Implementation Strategies |
| Authors: | 鄭曄
Cheng, Yeh |
| Contributors: | 陳敦源
Chen, Don-Yun
鄭曄
Cheng, Yeh |
| Keywords: | 子宮頸癌預防
人類乳突病毒預防針
政策分析
政策執行
執行策略
Cervical Cancer Prevention
Human Papillomavirus Vaccination
Policy analysis
Policy implementation
Implementation strategies |
| Date: | 2017 |
| Issue Date: | 2017-09-13 16:09:26 (UTC+8) |
| Abstract: | Cervical cancer is the second most common cancer that women suffer from worldwide. Every year more than 270,000 women die from cervical cancer, and it is one of the top ten cancer that Taiwanese women suffer from. Differ from other kinds of cancer, cervical cancer can be effectively prevented by vaccination, since most cervical cancers are caused by HPV(Human Papillomavirus) infection. HPV infection is most common in people in their late teens and early 20s, and the HPV vaccine targets the HPV types that most commonly cause cervical cancer and can cause some other cancers. It also protects against the HPV types that cause most genital warts. The HPV vaccine is highly effective in preventing the targeted HPV types, as well as the most common health problems caused by them.
Though HPV vaccination is included in the national immunization program in some countries, the vaccines are not provided to every female at no cost in Taiwan. While some cities and counties provides HPV vaccine for every female or a certain group of female gratuitously, female citizens of other cities and counties would have to pay approximately $300-360 USD for vaccination. This inconsistent policy among Taiwan has been questioned by local congressmen and citizens.
To re-examine the HPV vaccine policy and implementation procedure among each local government in Taiwan, the Health Promotion Administration, Ministry of Health and Welfare (HPA) as well as ten local governments with different HPV vaccination policies were interviewed and evaluated. The research concludes that with no united HPV vaccination policy, the goals of the policy among the local governments is different, some even undefined, the implementation levels of each local government is uneven, and misleading communication between the central and the local governments exist. A united policy with specific goal, implementation guidelines, report system, two-way communication system should and would make the vaccination policy more ample, and equal. |
| Reference: | Birkland, T. A., 2014. An Introduction to the Policy Process: Theories, Concepts and Models of Public Policy Making. U. K.: Routledge.
Chan, M. C., S. K. Chiu, C. C. Wu and C. T. Fang, 2013. “Human Papillomavirus Vaccination Policy: A Public Health Ethics Perspective,” Taiwan Journal of Public Health. 32(4):.309-319
Dey, Aditi, Stephanie Knox and Peter McIntyre, 2014. “Evaluation of the National Human Papillomavirus Vaccination Program,” Immunise Australia Program, Australian Government Department of Health.
(http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/evaluation-of-NHPVP) (2016/11/21)
Donovan, Denise, Ian McDowell and Duncan Hunter, 2017. Primer on Population Health. Ontario, Ottaw: The Association of Faculties of Medicine of Canada (https://phprimer.afmc.ca/medical-education/public-health) (2017/4/17)
Tsai, F. C. and B. Y. Chen., 2016. “The Ethical Issues Surrounding Vaccine Development and A Reflection on Vaccine Policies in Taiwan,” Department and Research Institute of Medical Education and Bioethics, January. 12(1): 4-12.
Gerston, L. N., 2014. Public Policy Making: Process and Principles. U. K.: Routledge.
Howlett, M., M. Ramesh, and A. Perl, 1995. Studying Public Policy: Policy Cycles and Policy Subsystems. Toronto: Oxford University Press.
ICO Information Centre on HPV and Cancer (HPV Information Centre), 2017. Human Papillomavirus and Related Diseases Report, Repubilc of Korea. ICO Information Centre on HPV and Cancer. (http://www.hpvcentre.net/statistics/reports/KOR.pdf) (2017/6/12)
Wen, L. F., L. C. Hung, and T. H. Chang, 2008. “Factors Associated with Adolescent Girls` Intention to self-paid Human Papillomavirus Vaccination,” Taiwan Journal of Public Health, 27(2):133-142.
Lin, J. W., W. Z. Cai, and Y. Z. Zeng, 2011. “Factors Associated with Parental Acceptance of Human Papillomavirus Vaccination for Adolescents,” Cheng Ching Medical Journal. 7(2):38-50.
Saslow, Debbie, Philip E. Castle, and 19 more, 2007.” American Cancer Society Guideline for Human Papillomavirus (HPV)Vaccine Use to Prevent CervicalCancer and Its Precursors,” CA: Cancer Journal for Clinicians. 51(1):7-28. (http://onlinelibrary.wiley.com/doi/10.3322/canjclin.57.1.7/epdf) (2016/11/21)
National Cervical Screening Programme, 2009. Prevention of Cervical Cancer A Guide for Women in New Zealand. Auckland & Wellington: New Zealand Ministry of Health. (https://www.healthed.govt.nz/resource/prevention-cervical-cancer-guide-women-new-zealand) (2016/12/12)
National Conference of State Legislatures, 2017. HPV Vaccine: State Legislation and Statutes. Denver and Washington: National Conference of State Legislatures. (http://www.ncsl.org/research/health/hpv-vaccine-state-legislation-and-statutes.aspx) (2017/06/13)
National Cancer Institute., 2016. Human Papillomavirus (HPV) Vaccines. Rockville, Maryland: NCI.(https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet) (2016/11/22)
New Zealand Ministry of Health., 2014. Cervical Cancer. Auckland:
New Zealand Ministry of Health. (http://www.health.govt.nz/your- health/conditions-and-treatments/diseases-and-illnesses/cervical-cancer) (2016/11/22)
New Zealand Ministry of Health., 2016. 2017 Immunisation Schedule Change. Auckland: New Zealand Ministry of Health. (http://www.health.govt.nz/our-work/preventative-health-wellness/immunisation/new-zealand-immunisation-schedule/2017-immunisation-schedule-change )(2017/06/09)
New Zealand Ministry of Health., 2017. HPV immunization Programme. Auckland: New Zealand Ministry of Health. (http://www.health.govt.nz/our-work/preventative-health-wellness/immunisation/hpv-immunisation-programme) (2017/05/05)
Singapore Health Services, 2014. Cervical Cancer. Singapore: Singapore Health Services. (https://www.singhealth.com.sg/PatientCare/ConditionsAndTreatments/Pages/cervical-cancer-prevention-and-screening.aspx ) (2016/12/12)
The American Cancer Society,2016. “HPV Vaccines,” Atlanta, Georgia: American Cancer Society.
(https://www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-vaccines.html) (2016/11/21)
The National Institute of Allergy and Infectious Diseases (NIAID), 2016. How Vaccine Works. Washington, D.C.:U.S. Department of Health and Human (https://www.vaccines.gov/basics/work/index.html )(2016/11/21)
The United Nations Children`s Fund (UNICF)., 2012. Communication for Development (C4D). Nigeria: The United Nations Children`s Fund (https://www.unicef.org/cbsc/index_42328.html ) (2016/12/21)
WHO., 2013. Comprehensive Cervical Cancer Prevention and Control: A Healthier Future for Girls and Women. Geneva: World Health Organization.
WHO, 2015. Practical Guide for the Design, Use and Promotion of Home Based Records in Immunization Programmes. Geneva: World Health Organization.
WHO., 2014. Evaluation of Seasonal Influenza Vaccination Policies and Coverage in the WHO European Region, Results From the 2008/2009 and 2009/2010 Influenza Seasons Based on a Joint VENICE–ECDC–WHO Survey. Geneva:World Health Organization.
WHO., 2016. HPV Vaccine Communication: Special Considerations for a Unique Vaccine. Geneva: World Health Organization.
WHO., 2016. HPV Vaccine Introduction Guide. Geneva: World Health Organization: 9-66.
WHO., 2016. Human papillomavirus (HPV) and cervical cancer Fact Sheets. Geneva :World Health Organization.
WHO, 2013. Vaccine Safety Events: Managing the Communication Response. Copenhagen, Denmark: WHO Regional Office for Europe.
DeRoeck, D., 2014. “Principles and considerations for adding a vaccine to a national immunization programme From Decision to Implementation and Monitoring,” World Health Organization. (http://apps.who.int/iris/ bitstream/10665/111548/1/9789241506892_eng.pdf) (2016/6/11)
Yu, Y, M Xu, J Sun, R Li, M Li, and J Wang, 2016. “Human Papillomavirus Infection and Vaccination: Awareness and Knowledge of HPV and Acceptability of HPV Vaccine among Mothers of Teenage Daughters in Weihai. Shandong, China.” San Francisco: Public Library of Science. 11(1): e0146741.
Zimet G. D., R. M. Mays and L. A. Stum, 2005. “Parent Attitudes about Sexually Transmitted Infection Vaccination for Their Adolescent Children.” US National Library of Medicine National Institutes of Health Search database. 159(2): 132-137.
台南市議會，2014。《莊玉珠議員---子宮頸癌疫苗免費施打何時上路? 》。台南市:台南市議會。
(http://www.tncc.gov.tw/chase.asp?type=chase&cid=%7B382A4734-2248-46ED-9703-7D8725F9280E%7D) (2016/12/12)
行政院衛生署國民健康局，2011。《第十次家庭與生育力調查報告》。台北市:衛生福利部國民健康署監測研究組。(http://health99.hpa.gov.tw/educZone/edu_detail.aspx?Catid=21685) (2016/08/14)
梁慧敏護理師，2007。《淺談子宮頸癌疫苗》， 《馬偕院訊》。2007年292期。
溫麗芬、洪麗珍、張彩秀，2008。「青少女自費接種子宮頸癌疫苗意向之相關因 素探討」, 『臺灣公共衛生雜誌』。 27卷，2期，頁133-142。
彭漣漪，2014。《打造出全台最幸福縣市》，2014年6月號《遠見雜誌》。《遠見雜誌》，第336期，頁169。
劉定萍、張峰義，2013。《感染與疫苗》。台北市: 行政院衛生署疾病管制局。(http://www.cdc.gov.tw/infectionreportinfo.aspx?treeid=075874dc882a5bfd&nowtreeid=91977f9e601d7b75&tid=a946742c06acbaa7) (2016/12/12)
衛生福利部統計處，2005-2015。《死因統計》。台北市: 衛生福利部統計處。
(http://dep.mohw.gov.tw/DOS/np-1776-113.html) (2017/06/13) |
| Description: | 碩士
國立政治大學
應用經濟與社會發展英語碩士學位學程(IMES)
10466008 |
| Source URI: | http://thesis.lib.nccu.edu.tw/record/#G0104266008 |
| Data Type: | thesis |
| Appears in Collections: | [應用經濟與社會發展英語碩士學位學程 (IMES)] 學位論文
|
Files in This Item:
There are no files associated with this item.
|
All items in 政大典藏 are protected by copyright, with all rights reserved.
|
